<DOC>
	<DOCNO>NCT01433666</DOCNO>
	<brief_summary>The aim current project validate PDE4 inhibitor target cognition enhancer ( proof-of-concept ) use translational behaviour-EEG approach . The project demonstrate whether memory , also attention , information processing executive function improve PDE4 inhibitor roflumilast healthy human .</brief_summary>
	<brief_title>Roflumilast Cognition</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<criteria>18 35 year age Healthy ( i.e . absence exclusion criterion ) , normal static binocular acuity ( correct uncorrected ) , Body mass index 18.5 30 Willingness sign inform consent . Positive evaluation memory screen History cardiac , hepatic , renal , pulmonary , neurological , gastrointestinal , haematological , psychiatric illness Firstdegree relative psychiatric disorder ( particular major depressive disorder suicidality ) Excessive drinking ( &gt; 20 glass alcohol contain beverage per week ) Pregnancy lactation Use chronic medication oral contraceptive Use recreational drug 2 week precede participation Smoking Orthostatic hypotension Lactose intolerance Sensory motor deficit could reasonably expect affect test performance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>